Every Form 4 that Bioceres Crop Solutions Corp. (BIOX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BIOX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BIOX filings page.
Bioceres Crop Solutions Corp. CEO and director Federico Trucco reported a bona fide gift transfer of 130,000 Ordinary Shares on 2026-05-20. The shares are held indirectly through Testamentario MQT Trust for the benefit of his child, and he disclaims beneficial ownership except for any pecuniary interest. Following the transaction, he also reports 226,000 Ordinary Shares held directly.
Bioceres Crop Solutions Corp. CEO and director Federico Trucco reported a bona fide gift transfer involving 150,000 Ordinary Shares on 2026-05-20, held indirectly through Testamentario MQT Trust for the benefit of his child. He disclaims beneficial ownership of these trust-held shares except for any pecuniary interest. Following the transactions, 150,000 Ordinary Shares are reported as held indirectly via the trust and 206,000 Ordinary Shares are reported as held directly.
Bioceres Crop Solutions Corp. reports that CFO Ezequiel Simmermacher received a grant of 375,000 Employee Stock Options (Right to Buy) covering 375,000 Ordinary Shares at an exercise price of 1.45 per share. The options were granted on August 3, 2026 under the 2023 Omnibus Equity Incentive Plan, vest annually in three equal installments commencing June 30, 2026, and expire on June 30, 2033. Following the grant, he holds 375,000 options directly.